Personal tools

MCL coexpression mm9:2960: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004121!8.60e-32!95;UBERON:0000924!8.60e-32!95;UBERON:0006601!8.60e-32!95;UBERON:0001017!4.56e-30!73;UBERON:0001016!5.23e-30!75;UBERON:0000073!1.57e-29!54;UBERON:0010371!5.09e-29!73;UBERON:0002346!8.78e-29!64;UBERON:0003075!8.78e-29!64;UBERON:0007284!8.78e-29!64;UBERON:0001049!6.72e-28!52;UBERON:0005068!6.72e-28!52;UBERON:0006241!6.72e-28!52;UBERON:0007135!6.72e-28!52;UBERON:0000955!9.62e-25!47;UBERON:0006238!9.62e-25!47;UBERON:0003056!3.04e-24!49;UBERON:0002616!5.11e-24!46;UBERON:0010314!1.19e-23!92;UBERON:0002020!2.33e-23!34;UBERON:0003080!2.13e-22!40;UBERON:0002780!6.70e-22!39;UBERON:0001890!6.70e-22!39;UBERON:0006240!6.70e-22!39;UBERON:0003528!9.03e-20!29;UBERON:0002791!9.03e-20!29;UBERON:0001893!9.03e-20!29;UBERON:0000956!2.61e-14!21;UBERON:0001869!2.61e-14!21;UBERON:0000203!2.61e-14!21;UBERON:0002619!1.85e-12!17;UBERON:0002021!4.63e-09!10;UBERON:0000411!4.63e-09!10;UBERON:0001950!4.63e-09!10;UBERON:0000025!1.95e-07!114;UBERON:0004111!6.35e-07!122
|ontology_enrichment_uberon=UBERON:0004121!8.60e-32!95;UBERON:0000924!8.60e-32!95;UBERON:0006601!8.60e-32!95;UBERON:0001017!4.56e-30!73;UBERON:0001016!5.23e-30!75;UBERON:0000073!1.57e-29!54;UBERON:0010371!5.09e-29!73;UBERON:0002346!8.78e-29!64;UBERON:0003075!8.78e-29!64;UBERON:0007284!8.78e-29!64;UBERON:0001049!6.72e-28!52;UBERON:0005068!6.72e-28!52;UBERON:0006241!6.72e-28!52;UBERON:0007135!6.72e-28!52;UBERON:0000955!9.62e-25!47;UBERON:0006238!9.62e-25!47;UBERON:0003056!3.04e-24!49;UBERON:0002616!5.11e-24!46;UBERON:0010314!1.19e-23!92;UBERON:0002020!2.33e-23!34;UBERON:0003080!2.13e-22!40;UBERON:0002780!6.70e-22!39;UBERON:0001890!6.70e-22!39;UBERON:0006240!6.70e-22!39;UBERON:0003528!9.03e-20!29;UBERON:0002791!9.03e-20!29;UBERON:0001893!9.03e-20!29;UBERON:0000956!2.61e-14!21;UBERON:0001869!2.61e-14!21;UBERON:0000203!2.61e-14!21;UBERON:0002619!1.85e-12!17;UBERON:0002021!4.63e-09!10;UBERON:0000411!4.63e-09!10;UBERON:0001950!4.63e-09!10;UBERON:0000025!1.95e-07!114;UBERON:0004111!6.35e-07!122
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,1.23467,0.870507,0.906098,0.467629,0.933025,1.47843,0,1.14208,0.578045,0.448066,0.328717,0.679146,1.38557,0.932027,0.585919,0.731217,0.963352,1.1146,0.841386,2.62594,0.99159,0.825437,1.24901,0.575271,0.411696,0.608816,0.872889,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.724277,0.610669,0.922882,0.788421,1.05665,0.859154,0.663409,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.777706,1.44925,3.83376,0.402065,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,0.181575,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,1.1471,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.38417,0.260379,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,1.38188,0.904334,0.421338
}}
}}

Revision as of 22:12, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr15:103364823..103364835,-p@chr15:103364823..103364835
-
Mm9::chr15:103368359..103368450,-p1@Ppp1r1a
Mm9::chr15:103368452..103368463,-p2@Ppp1r1a


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)5.43e-1423
neuroblast (sensu Vertebrata)5.43e-1423
neural cell2.69e-1243
ectodermal cell2.85e-1244
neurectodermal cell2.85e-1244
neuron9.58e-1033
neuronal stem cell9.58e-1033
neuroblast9.58e-1033
electrically signaling cell9.58e-1033
non-terminally differentiated cell5.29e-0949

Uber Anatomy
Ontology termp-valuen
ectoderm-derived structure8.60e-3295
ectoderm8.60e-3295
presumptive ectoderm8.60e-3295
central nervous system4.56e-3073
nervous system5.23e-3075
regional part of nervous system1.57e-2954
ecto-epithelium5.09e-2973
neurectoderm8.78e-2964
neural plate8.78e-2964
presumptive neural plate8.78e-2964
neural tube6.72e-2852
neural rod6.72e-2852
future spinal cord6.72e-2852
neural keel6.72e-2852
brain9.62e-2547
future brain9.62e-2547
pre-chordal neural plate3.04e-2449
regional part of brain5.11e-2446
structure with developmental contribution from neural crest1.19e-2392
gray matter2.33e-2334
anterior neural tube2.13e-2240
regional part of forebrain6.70e-2239
forebrain6.70e-2239
future forebrain6.70e-2239
brain grey matter9.03e-2029
regional part of telencephalon9.03e-2029
telencephalon9.03e-2029
cerebral cortex2.61e-1421
cerebral hemisphere2.61e-1421
pallium2.61e-1421
regional part of cerebral cortex1.85e-1217
occipital lobe4.63e-0910
visual cortex4.63e-0910
neocortex4.63e-0910
tube1.95e-07114
anatomical conduit6.35e-07122


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}